These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26911998)

  • 1. Global fund financing to the 34 malaria-eliminating countries under the new funding model 2014-2017: an analysis of national allocations and regional grants.
    Zelman B; Melgar M; Larson E; Phillips A; Shretta R
    Malar J; 2016 Feb; 15():118. PubMed ID: 26911998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of eliminating malaria and the impact of the global fund in 34 countries.
    Zelman B; Kiszewski A; Cotter C; Liu J
    PLoS One; 2014; 9(12):e115714. PubMed ID: 25551454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
    Schmidt-Traub G
    Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening.
    Bowser D; Sparkes SP; Mitchell A; Bossert TJ; Bärnighausen T; Gedik G; Atun R
    Health Policy Plan; 2014 Dec; 29(8):986-97. PubMed ID: 24197405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operational and implementation research within Global Fund to Fight AIDS, Tuberculosis and Malaria grants: a situation analysis in six countries.
    Kiefer S; Knoblauch AM; Steinmann P; Barth-Jaeggi T; Vahedi M; Maher D; Utzinger J; Wyss K
    Global Health; 2017 Mar; 13(1):22. PubMed ID: 28340619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
    Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
    Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation.
    Lu C; Michaud CM; Khan K; Murray CJ
    Lancet; 2006 Aug; 368(9534):483-8. PubMed ID: 16890835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality changes after grants from the Global Fund to Fight AIDS, tuberculosis and malaria: an econometric analysis from 1995 to 2010.
    Yan I; Korenromp E; Bendavid E
    BMC Public Health; 2015 Sep; 15():977. PubMed ID: 26416543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
    Kerouedan D
    Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Global Fund to Fight AIDS, Tuberculosis and Malaria: 10 years on.
    Hanefeld J
    Clin Med (Lond); 2014 Feb; 14(1):54-7. PubMed ID: 24532746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating operational research in programmes funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria in four sub-Saharan African countries.
    Camacho S; Maher D; Kamau EM; Saric J; Segura L; Zachariah R; Wyss K
    Global Health; 2020 Jul; 16(1):67. PubMed ID: 32711553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global health initiative investments and health systems strengthening: a content analysis of global fund investments.
    Warren AE; Wyss K; Shakarishvili G; Atun R; de Savigny D
    Global Health; 2013 Jul; 9(1):30. PubMed ID: 23889824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission.
    Snow RW; Guerra CA; Mutheu JJ; Hay SI
    PLoS Med; 2008 Jul; 5(7):e142. PubMed ID: 18651785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedicated health systems strengthening of the Global Fund to Fight AIDS, Tuberculosis, and Malaria: an analysis of grants.
    Fan VY; Tsai FJ; Shroff ZC; Nakahara B; Vargha N; Weathers S
    Int Health; 2017 Jan; 9(1):50-57. PubMed ID: 27986840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments.
    Snow RW; Okiro EA; Gething PW; Atun R; Hay SI
    Lancet; 2010 Oct; 376(9750):1409-16. PubMed ID: 20889199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parasites and vectors carry no passport: how to fund cross-border and regional efforts to achieve malaria elimination.
    Gueye CS; Teng A; Kinyua K; Wafula F; Gosling R; McCoy D
    Malar J; 2012 Oct; 11():344. PubMed ID: 23057734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How a new funding model will shift allocations from the Global Fund to Fight AIDS, tuberculosis, and malaria.
    Fan VY; Glassman A; Silverman RL
    Health Aff (Millwood); 2014 Dec; 33(12):2238-46. PubMed ID: 25392001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003-12.
    Fan VY; Duran D; Silverman R; Glassman A
    Lancet Glob Health; 2013 Sep; 1(3):e161-8. PubMed ID: 25104264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaling up towards international targets for AIDS, tuberculosis, and malaria: contribution of global fund-supported programs in 2011-2015.
    Katz I; Komatsu R; Low-Beer D; Atun R
    PLoS One; 2011 Feb; 6(2):e17166. PubMed ID: 21383839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.